85 related articles for article (PubMed ID: 23948948)
1. Intravitreal functional plasminogen is elevated in central retinal vein occlusion.
Bertelmann T; Mennel S; Sekundo W; Strodthoff S; Witteborn MC; Stief T; Nguyen N; Koss MJ
Ophthalmic Res; 2013; 50(3):151-9. PubMed ID: 23948948
[TBL] [Abstract][Full Text] [Related]
2. Intravitreal functional plasminogen in eyes with branch retinal vein occlusion.
Bertelmann T; Sekundo W; Strodthoff S; Witteborn MC; Stief T; Irle S; Nguyen N; Koss MJ; Mennel S
Ophthalmic Res; 2014; 52(2):74-80. PubMed ID: 25059575
[TBL] [Abstract][Full Text] [Related]
3. Comparison of cytokine levels from undiluted vitreous of untreated patients with retinal vein occlusion.
Koss MJ; Pfister M; Rothweiler F; Michaelis M; Cinatl J; Schubert R; Koch FH
Acta Ophthalmol; 2012 Mar; 90(2):e98-e103. PubMed ID: 22066978
[TBL] [Abstract][Full Text] [Related]
4. Vitreous levels of interleukin-6 and vascular endothelial growth factor in macular edema with central retinal vein occlusion.
Noma H; Funatsu H; Mimura T; Harino S; Hori S
Ophthalmology; 2009 Jan; 116(1):87-93. PubMed ID: 19118700
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal tissue plasminogen activator for acute central retinal vein occlusion.
Lahey JM; Fong DS; Kearney J
Ophthalmic Surg Lasers; 1999 Jun; 30(6):427-34. PubMed ID: 10392729
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal thrombin activity is elevated in retinal vein occlusion.
Bertelmann T; Stief T; Sekundo W; Mennel S; Nguyen N; Koss MJ
Blood Coagul Fibrinolysis; 2014 Oct; 25(7):654-9. PubMed ID: 24625582
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor and interleukin-6 are correlated with serous retinal detachment in central retinal vein occlusion.
Noma H; Funatsu H; Mimura T
Curr Eye Res; 2012 Jan; 37(1):62-7. PubMed ID: 21978265
[TBL] [Abstract][Full Text] [Related]
8. The impact of posterior vitreous adhesion on ischaemia in eyes with retinal vein occlusion.
Bertelmann T; Kicova N; Mennel S; Schmidt J; Irle S; Sekundo W; Schulze S
Acta Ophthalmol; 2016 Feb; 94(1):e43-8. PubMed ID: 26290142
[TBL] [Abstract][Full Text] [Related]
9. Role of posterior vitreous detachment induced by intravitreal tissue plasminogen activator in macular edema with central retinal vein occlusion.
Murakami T; Takagi H; Ohashi H; Kita M; Nishiwaki H; Miyamoto K; Watanabe D; Sakamoto A; Yamaike N; Yoshimura N
Retina; 2007 Oct; 27(8):1031-7. PubMed ID: 18040240
[TBL] [Abstract][Full Text] [Related]
10. Retinal endovascular lysis in ischemic central retinal vein occlusion: one-year results of a pilot study.
Feltgen N; Junker B; Agostini H; Hansen LL
Ophthalmology; 2007 Apr; 114(4):716-23. PubMed ID: 17141322
[TBL] [Abstract][Full Text] [Related]
11. [Intravitreal fibrinolysis and retinal vein occlusion].
Bertelmann T; Stief T; Sekundo W; Witteborn M; Strodthoff S; Mennel S; Nguyen N; Koss M
Ophthalmologe; 2015 Feb; 112(2):155-61. PubMed ID: 25305042
[TBL] [Abstract][Full Text] [Related]
12. Comparison of intravitreal bevacizumab upload followed by a dexamethasone implant versus dexamethasone implant monotherapy for retinal vein occlusion with macular edema.
Mayer WJ; Remy M; Wolf A; Kook D; Kampik A; Ulbig M; Reznicek L; Haritoglou C
Ophthalmologica; 2012; 228(2):110-6. PubMed ID: 22739239
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of angiogenic and inflammatory proteins in the vitreous of patients with ischemic central retinal vein occlusion.
Ehlken C; Grundel B; Michels D; Junker B; Stahl A; Schlunck G; Hansen LL; Feltgen N; Martin G; Agostini HT; Pielen A
PLoS One; 2015; 10(5):e0126859. PubMed ID: 25978399
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal triamcinolone acetonide for cystoid macular edema in nonischemic central retinal vein occlusion.
Williamson TH; O'Donnell A
Am J Ophthalmol; 2005 May; 139(5):860-6. PubMed ID: 15860292
[TBL] [Abstract][Full Text] [Related]
15. Vitreous inflammatory factors and serous macular detachment in branch retinal vein occlusion.
Noma H; Funatsu H; Mimura T; Tatsugawa M; Shimada K; Eguchi S
Retina; 2012 Jan; 32(1):86-91. PubMed ID: 21866074
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal bevacizumab injections for treatment of central retinal vein occlusion: six-month results of a prospective trial.
Priglinger SG; Wolf AH; Kreutzer TC; Kook D; Hofer A; Strauss RW; Alge CS; Kunze C; Haritoglou C; Kampik A
Retina; 2007 Oct; 27(8):1004-12. PubMed ID: 18040236
[TBL] [Abstract][Full Text] [Related]
17. Levels of VEGF but not VEGF(165b) are increased in the vitreous of patients with retinal vein occlusion.
Ehlken C; Rennel ES; Michels D; Grundel B; Pielen A; Junker B; Stahl A; Hansen LL; Feltgen N; Agostini HT; Martin G
Am J Ophthalmol; 2011 Aug; 152(2):298-303.e1. PubMed ID: 21621189
[TBL] [Abstract][Full Text] [Related]
18. Fibrinolysis in normal vitreous liquid.
Bertelmann T; Stief T; Bölöni R; Schulze S; Wenner Y; Sekundo W; Mennel S
Blood Coagul Fibrinolysis; 2014 Apr; 25(3):217-20. PubMed ID: 24247317
[TBL] [Abstract][Full Text] [Related]
19. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion.
Haller JA; Bandello F; Belfort R; Blumenkranz MS; Gillies M; Heier J; Loewenstein A; Yoon YH; Jacques ML; Jiao J; Li XY; Whitcup SM;
Ophthalmology; 2010 Jun; 117(6):1134-1146.e3. PubMed ID: 20417567
[TBL] [Abstract][Full Text] [Related]
20. Retinal vein occlusion and low-dose fibrinolytic therapy (R.O.L.F.): a prospective, randomized, controlled multicenter study of low-dose recombinant tissue plasminogen activator versus hemodilution in retinal vein occlusion.
Hattenbach LO; Friedrich Arndt C; Lerche R; Scharrer I; Baatz H; Margaron F; Richard G; Behrens-Baumann W; Ohrloff C
Retina; 2009; 29(7):932-40. PubMed ID: 19584651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
